欧盟委员会批准复宏汉霖和Organon公司的Bildyos®(地诺单抗)和Bilprevda®(地诺单抗)生物类似药,分别为Prolia(地诺单抗)和Xgeva(地诺单抗)的生物类似药
欧盟委员会批准复宏汉霖和Organon公司的Bildyos®(地诺单抗)和Bilprevda®(地诺单抗)生物类似药,分别为Prolia(地诺单抗)和Xgeva(地诺单抗)的生物类似药
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.